Joint, JYNT is showing recent insider trading activity. Public SEC records indicate that Peter Holt recently Bought $49,853 worth of shares on 2 years ago. With that said, our editors here at politicsandwallstreet.com, are adding JYNT to our watchlist to see if this momentum continues.
Based on this transaction and a few others from Corporate Insiders of JYNT that Sold 534,000 worth of shares in the last 3 months, the Insider Confidence level of Joint is trending Down.
Since these insiders have unique insights into what's happening at Joint, this might serve as an indicator of where it is headed.
Here is a list of the latest insider activity for JYNT:
In addition, TradingView issued a sell rating for JYNT over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Neutral short-term outlook.
Jeremy Hamblin
Here is a bit more on Joint, JYNT but please do your own research.
JYNT Summary: The Joint Corp. is a healthcare franchisor of chiropractic clinics. The Company's plans include: Single Visit, Premium Wellness Plan and Wellness Plan. It also provides a family wellness plan. The Company also provides removal of subluxations. It operates its clinics across: Albany, New York; Austin, Texas; Brentwood, California; Fort Mill, South Carolina; Lubbock, Texas; Lynnwood, Washington; Middletown, New Jersey; San Antonio, Texas; San Diego, California and Spartanburg, South Carolina, among others. The Joint Corp. is headquartered in Scottsdale, Arizona.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
This information was sourced from various 3rd party public sources but to get the best insight into insider activity related to JYNT, you should consider joining TipRanks.com.
PoliticsAndWallStreet.com
Disclaimer: Sandpiper Marketing Group, LLC would like to remind you the data contained in this website is not necessarily real-time nor accurate. All stocks, indexes, futures and Forex prices are not provided by exchanges but rather by our editor research at the time of writing this release, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Sandpiper Marketing does not bear any responsibility for any trading losses you might incur as a result of using this data. Sandpiper Marketing Group, LLC or anyone involved with Sandpiper Marketing Group, LLC will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this website/newsletter is not trustworthy unless verified by their own research. Also, because events/circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
==============================================================================
Based on this transaction and a few others from Corporate Insiders of JYNT that Sold 534,000 worth of shares in the last 3 months, the Insider Confidence level of Joint is trending Down.
Since these insiders have unique insights into what's happening at Joint, this might serve as an indicator of where it is headed.
Here is a list of the latest insider activity for JYNT:
- Peter Holt - director, Bought $49,853 worth of shares on 1 year ago
- Ronald DaVella - officer: President and CEO, Sold $158,935 worth of shares on 2 years ago
- Ronald DaVella - director, Sold $512,614 worth of shares on 2 years ago
- Ronald DaVella - director, Sold $767,492 worth of shares on 2 years ago
In addition, TradingView issued a sell rating for JYNT over the next month, Barchart.com has a Strong sell rating and Yahoo! Finance has a Neutral short-term outlook.
Jeremy Hamblin
Here is a bit more on Joint, JYNT but please do your own research.
JYNT Summary: The Joint Corp. is a healthcare franchisor of chiropractic clinics. The Company's plans include: Single Visit, Premium Wellness Plan and Wellness Plan. It also provides a family wellness plan. The Company also provides removal of subluxations. It operates its clinics across: Albany, New York; Austin, Texas; Brentwood, California; Fort Mill, South Carolina; Lubbock, Texas; Lynnwood, Washington; Middletown, New Jersey; San Antonio, Texas; San Diego, California and Spartanburg, South Carolina, among others. The Joint Corp. is headquartered in Scottsdale, Arizona.
- Recent Last Price: $9.12
- Price Change: -$0.13, -1.41%
- Yearly Gain: -42.19%
- Market Cap: $136.48M
- P/E Ratio: 45.566
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
This information was sourced from various 3rd party public sources but to get the best insight into insider activity related to JYNT, you should consider joining TipRanks.com.
PoliticsAndWallStreet.com
Disclaimer: Sandpiper Marketing Group, LLC would like to remind you the data contained in this website is not necessarily real-time nor accurate. All stocks, indexes, futures and Forex prices are not provided by exchanges but rather by our editor research at the time of writing this release, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Sandpiper Marketing does not bear any responsibility for any trading losses you might incur as a result of using this data. Sandpiper Marketing Group, LLC or anyone involved with Sandpiper Marketing Group, LLC will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in this website/newsletter is not trustworthy unless verified by their own research. Also, because events/circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
==============================================================================
